Special Issue "Biologics"

Quicklinks

A special issue of Pharmaceuticals (ISSN 1424-8247).

Deadline for manuscript submissions: closed (31 January 2013)

Special Issue Editor

Guest Editor
Dr. Christine Brezden-Masley
St. Michael’s Hospital, 30 Bond Street, Room 2046, Toronto, Ontario, Canada
E-Mail: brezdenc@smh.ca
Interests: cytotoxic chemotherapeutics; molecular-targeted biologics; breast cancer pathophysiology; diagnostic imaging; patient safety

Special Issue Information

Submission

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed Open Access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 800 CHF (Swiss Francs).

Keywords

  • novel molecular targets of cancer pathogenesist
  • tumour biomarkers
  • novel tyrosine kinase inhibitors
  • molecular targeted monoclonal antibodies
  • targets of tumorigenesis
  • pathways of inhibition of tumorigenesis

Published Papers (8 papers)

Download All Papers
Sort by:
Display options:
Select articles Export citation of selected articles as:
Select/unselect all
Displaying article 1-8
p. 1322-1334
by , ,  and
Pharmaceuticals 2013, 6(10), 1322-1334; doi:10.3390/ph6101322
Received: 2 July 2013; in revised form: 2 October 2013 / Accepted: 9 October 2013 / Published: 16 October 2013
Show/Hide Abstract | PDF Full-text (252 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Biologics)
p. 681-688
by ,  and
Pharmaceuticals 2013, 6(5), 681-688; doi:10.3390/ph6050681
Received: 5 February 2013; in revised form: 23 April 2013 / Accepted: 8 May 2013 / Published: 14 May 2013
Show/Hide Abstract | Cited by 2 | PDF Full-text (134 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Biologics)
abstract graphic
p. 579-603
by ,  and
Pharmaceuticals 2013, 6(5), 579-603; doi:10.3390/ph6050579
Received: 1 March 2013; in revised form: 28 March 2013 / Accepted: 10 April 2013 / Published: 26 April 2013
Show/Hide Abstract | Cited by 9 | PDF Full-text (476 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Biologics)
p. 557-578
by  and
Pharmaceuticals 2013, 6(4), 557-578; doi:10.3390/ph6040557
Received: 31 January 2013; in revised form: 26 February 2013 / Accepted: 7 April 2013 / Published: 17 April 2013
Show/Hide Abstract | Cited by 1 | PDF Full-text (485 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Biologics)
p. 358-392
by  and
Pharmaceuticals 2013, 6(3), 358-392; doi:10.3390/ph6030358
Received: 28 January 2013; in revised form: 20 February 2013 / Accepted: 5 March 2013 / Published: 21 March 2013
Show/Hide Abstract | PDF Full-text (577 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Biologics)
p. 393-406
by ,  and
Pharmaceuticals 2013, 6(3), 393-406; doi:10.3390/ph6030393
Received: 29 January 2013; Accepted: 13 March 2013 / Published: 21 March 2013
Show/Hide Abstract | Cited by 1 | PDF Full-text (697 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Biologics)
p. 353-368
by  and
Pharmaceuticals 2012, 5(4), 353-368; doi:10.3390/ph5040353
Received: 20 February 2012; in revised form: 20 March 2012 / Accepted: 28 March 2012 / Published: 30 March 2012
Show/Hide Abstract | Cited by 8 | PDF Full-text (97 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Biologics)
p. 79-93
by , , , ,  and
Pharmaceuticals 2012, 5(1), 79-93; doi:10.3390/ph5010079
Received: 16 November 2011; in revised form: 14 December 2011 / Accepted: 22 December 2011 / Published: 5 January 2012
Show/Hide Abstract | Cited by 5 | PDF Full-text (699 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Biologics)
Select/unselect all
Displaying article 1-8
Select articles Export citation of selected articles as:

Last update: 19 July 2013

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert